The symptoms of Human Immunodeficiency Virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS) exhibit phased characteristics, with the progression divided into the acute infection phase, asymptomatic latent phase, and the late stage with severe immune system impairment. Initial symptoms may be mistaken for a common cold or flu, leading to delays in seeking medical attention, while later symptoms are directly related to immune system decline and may trigger various complications. Early diagnosis and treatment can effectively delay disease progression, making it crucial to understand the symptom characteristics at each stage to prevent severe complications.
In the early stages of HIV infection, symptoms can vary widely; some patients may be completely asymptomatic, while others may experience flu-like acute reactions within 2 to 4 weeks post-infection. As the virus replicates in the body, the immune system responds, but these early signs are often overlooked. When the disease progresses to the stage of AIDS, symptoms become more complex and severe, including opportunistic infections and the emergence of specific cancers. Recognizing these symptom differences aids in early detection and medical intervention, reducing transmission risk.
Acute symptoms after HIV infection typically appear 2 to 4 weeks after exposure, with about 50% to 70% of patients experiencing mild to moderate symptoms. Typical signs during this phase include fever, headache, muscle and joint pain, sore throat, and swollen lymph nodes. These symptoms may be misdiagnosed as a common cold or mononucleosis, resulting in patients not undergoing timely HIV screening.
Characteristic symptoms of this phase include:
After the acute phase, HIV may enter an asymptomatic latent phase lasting several years or even a decade. During this stage, patients may feel completely normal, but the virus continues to destroy CD4+ T cells in the immune system. A few individuals in this phase may occasionally experience mild upper respiratory infection symptoms or recurrent mild fever and fatigue due to immune system abnormalities.
The hidden nature of this phase makes regular screening particularly important, especially for high-risk groups. Even in the absence of obvious symptoms, the virus may still be transmitted to others through asymptomatic blood or bodily fluids. Medical research indicates that about 10% to 20% of patients may experience intermittent fever or unexplained weight loss in the late latent phase, which could be misinterpreted as other chronic diseases.
As the immune system becomes more compromised, patients will begin to exhibit clearer HIV-related symptoms. Common symptoms include persistent fatigue, unexplained weight loss (more than 5% of body weight in a month), prolonged fever lasting more than several weeks, and recurrent bacterial or fungal infections. These symptoms are directly related to the decline in CD4+ T cell counts, and when the CD4 cell count drops below 200 cells/mm³, it meets the diagnostic criteria for AIDS.
Gastrointestinal-related symptoms are also very common, including chronic diarrhea, nausea, loss of appetite, and difficulty swallowing. These symptoms may arise from the virus directly invading the gastrointestinal mucosa or from bacterial gastroenteritis due to decreased immunity. Oral and genital ulcers, along with recurrent fungal infections (such as candidiasis), are also early signs of immune system collapse.
Neurological symptoms gradually emerge in the mid-stages of the disease, which may include memory impairment, difficulty concentrating, limb numbness due to peripheral neuropathy, and possible mild cognitive dysfunction. Skin symptoms may include generalized rashes, seborrheic dermatitis, and rare skin lesions such as Kaposi's sarcoma, which are often seen as indicators of severe immune system impairment.
Skin-related symptoms may accompany damage to other systems, such as skin inflammation occurring alongside painless swollen lymph nodes or skin ulcers with recurrent infections. The combination of these symptoms indicates that the immune surveillance mechanism has been severely compromised, necessitating immediate immune function assessment and viral load measurement.
The process from HIV infection to the development of AIDS involves an increasing severity and variety of symptoms. When CD4+ T cell counts continue to decline below 50 cells/mm³, patients face a high risk of multiple life-threatening infections. Symptoms at this stage may include severe pneumonia, Pneumocystis pneumonia, and treatment-resistant tuberculosis.
Common opportunistic infections in the late stage include cryptococcal meningitis and toxoplasmosis, which are usually harmless in immunocompetent individuals but can pose a fatal threat to HIV patients. Additionally, tumor-related symptoms such as rapid dissemination of Kaposi's sarcoma or severe lymph node enlargement in non-Hodgkin lymphoma are significant warning signs in the late stage.
In the late stages of the disease, damage to the brain and nervous system can lead to cognitive dysfunction and motor coordination disorders, with severe cases possibly resulting in HIV-associated neurocognitive disorders. The respiratory system may experience persistent dry cough, shortness of breath, and decreased blood oxygen saturation due to Pneumocystis pneumonia or tuberculosis infection.
Even in the absence of obvious symptoms, individuals meeting any of the following conditions should undergo HIV screening immediately: having unprotected sex in the last 3 months, a history of shared needle use, or contact with bodily fluids from an HIV-positive individual. Even if only mild flu-like symptoms are present, if accompanied by recent high-risk behaviors, it should be treated as an urgent medical alert.
When experiencing unexplained rapid weight loss (more than 10% within 6 months), persistent fever lasting more than 1 month, or recurrent severe infections, one should immediately visit an infectious disease or immunology clinic for a complete examination. Even if symptoms seem similar to other chronic diseases, the possibility of HIV infection must be ruled out.
Pregnant women, children, and immunocompromised patients may exhibit different symptom patterns. Pregnant women may show specific signs such as abnormal uterine contractions or decreased fetal movement when transmitting the virus to the fetus in utero; pediatric patients may be discovered due to abnormal vaccine reactions or recurrent severe ear infections.
Patients receiving antiretroviral therapy, if they suddenly stop medication or develop resistance, may experience a "symptom rebound" phenomenon within weeks, including exacerbation of existing symptoms or new neurological symptoms. Such situations require immediate return to the hospital for treatment adjustment.
The side effects of antiretroviral therapy vary among individuals, but modern medications have significantly reduced toxicity. Common mild reactions may include headaches, diarrhea, or fatigue, but most patients can alleviate these by adjusting their medication regimen. If following medical advice and undergoing regular follow-ups, the benefits of treatment far outweigh potential risks, and it effectively suppresses viral activity.
Can I get HIV by sharing kitchen utensils or coming into contact with tears of an HIV-positive person?HIV cannot be transmitted through casual contact. Sharing utensils, coming into contact with tears, or intact skin does not allow the virus to penetrate mucous membranes or skin. Infection primarily occurs through direct exchange of blood, semen, vaginal secretions, or breast milk; everyday interactions pose no risk.
Do HIV patients need to regularly check their immune index after starting treatment?Yes, even if the viral load is undetectable, regular monitoring of CD4 immune cell counts and viral load remains crucial. This helps track the recovery of the immune system and ensures treatment stability. Interrupting follow-ups may lead to viral rebound or resistance, so medical guidelines recommend checking every 3-6 months.
What are the key differences in timing between post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP)?Post-exposure prophylaxis (PEP) must be started within 72 hours after potential exposure to the virus and continued for 28 days, used in emergency situations such as needle stick injuries or sexual assault. Pre-exposure prophylaxis (PrEP) is a long-term preventive measure for uninfected individuals, requiring daily medication and regular screening; the timing and target populations for both are entirely different.
How can I detect early symptoms of HIV infection, which are difficult to distinguish from a common flu?Early acute infections may present with fever, swollen lymph nodes, and other nonspecific symptoms, but these can easily be confused with a cold. The most reliable method is through blood antibody/antigen testing, especially conducting fourth-generation tests 2-4 weeks after potential exposure, which can detect viral nucleic acids early. If experiencing unexplained long-term fever or unknown rashes, seek medical attention immediately and proactively inform about risk behaviors.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
